Compared with the general public, people in prison in the EU/EEA have a higher burden of communicable diseases such as human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis, gonorrhoea, chlamydia and tuberculosis (TB). Increased disease prevalence in this population is...

This guide and the associated package of online materials provides a reference point for those planning or delivering health and social responses to drug problems in Europe. The most appropriate responses will depend on the specific drug problems, the contexts in which these occur and the types...

This guide and the associated package of online materials provides a reference point for those planning or delivering health and social responses to drug problems in Europe. The most appropriate responses will depend on the specific drug problems, the contexts in which these occur and the types...

This guide and the associated package of online materials provides a reference point for those planning or delivering health and social responses to drug problems in Europe. The most appropriate responses will depend on the specific drug problems, the contexts in which these occur and the types...

Since the emergence of the HIV epidemic among people who inject drugs in the mid-1980s, many European countries have achieved substantial progress in implementing evidence-based measures to prevent and control infectious diseases among this group. In the 1990s, EU countries started to develop...

This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs. The guidance identifies seven key interventions which, in...

Since the emergence of the HIV epidemic among people who inject drugs in the mid-1980s, many European countries have achieved substantial progress in implementing evidence-based measures to prevent and control infectious diseases among this group. In the 1990s, EU countries started to develop...

Compared with the general public, people in prison in the EU/EEA have a higher burden of communicable diseases such as human immunodeficiency virus (HIV), hepatitis B, hepatitis C, syphilis, gonorrhoea, chlamydia and tuberculosis (TB). Increased disease prevalence in this population is...

This miniguide on responding to drug-related infectious diseases is one of a larger set, which together comprise Health and social responses to drug problems: a European guide 2021. It provides an overview of the most important aspects to consider when planning or delivering health and social...

In 2016, the World Health Assembly endorsed the first global health sector strategy on viral hepatitis. The aim of the strategy is to eliminate viral hepatitis as a major public health threat by 2030. In Europe, people who inject drugs (PWID) are at high risk of hepatitis C virus (HCV) and...